Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.70
Bid: 2.60
Ask: 2.80
Change: -0.10 (-3.85%)
Spread: 0.20 (7.692%)
Open: 2.60
High: 2.50
Low: 2.50
Prev. Close: 2.60
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Nyota Minerals, Mariana Resources, Bluestar...

Thu, 17th Jun 2010 08:14

Miner Nyota Minerals said drilling at its flagship Tulu Kapi gold project in Ethiopia has confirmed the presence of a new mineralized structure beneath the inferred resource of 1.38m ounces of gold.Also in gold mining, Mariana Resources said it made an encouraging intersection of gold north of the Belleza prospect in Chile.Chinese digital video surveillance firm BlueStar SecuTech has won a new contract with the Tangshan Public Security Bureau worth about RMB 9 million (£0.9 million). The contract is to provide networked surveillance services and solutions at approximately 300 Police Stations and 15 Police Security Bureaus in Tangshan City. This is BlueStar's first networking project with a municipal Public Security Bureau. Once the project has been successfully completed, BlueStar management believes it can be replicated in other cities across China according to the requirement by The Ministry of Public Security of China.Drug delivery and device technologies firm Consort Medical saw pre-tax profit fall 13% to £10.5m on revenue that fell to £118.6m from £120.3m before.The group said the results were due to the group facing destocking across its markets during the year, a material price reduction in one of Bespak's key contracts and a weak hospital market in the US for King Systems. Final dividend was maintained at 12.1p per share.Marketing services company Work Group said Rose Colledge will be appointed group chief executive with effect from June 21st, while finance director Michael Warren has decided to step down with effect from July 31st. "We have maintained our broad spread of clients and only 10 per cent of our income is derived from public sector organisations. Consequently we see no reason why expectations for the current year will not be met," said the group.Biopharmaceutical tiddler Valirx said it has now completed the first year of a two year Eurostars grant programme in which all developmental milestones have been met.
More News
11 Feb 2015 08:39

ValiRx Shares Up On European Patent For Biomarker Testing Method

Read more
5 Feb 2015 08:18

ValiRx Buys Finnish Gene Expression And Biomarker Technology

Read more
15 Jan 2015 10:36

ValiRx Expects First VAL201 Results In 1st Quarter; VAL401 Progresses

Read more
13 Nov 2014 09:47

ValiRx Enters Collaboration Agreement For GeneICE Development

Read more
3 Nov 2014 11:09

ValiRx VAL201 PhaseI/II Trial Progressing In Line With Plan

Read more
14 Oct 2014 09:22

ValiRx VAL201 Phase I/II Trial Ready To Begin Recruitment

Read more
8 Oct 2014 15:31

ValiRx Completes YA Global Master Equity Swap Deal Early

Read more
2 Sep 2014 09:27

Valirx's lung cancer treatment receives positive results

Valirx, the developer and producer of technology used in oncology therapeutics, has received positive results from the studies on one of its lung cancer treatments. The studies on treatment VAL401 were carried out by Valiseek, Valirx's joint venture company with Tangent Reprofiling, and demonstrate

Read more
2 Sep 2014 07:26

UK MORNING BRIEFING: Weir Group Leads Firm London Market On Upgrade

Read more
2 Sep 2014 06:40

ValiRx Says Preclinical Trials For VAL401 In Lung Cancer Positive

Read more
19 Aug 2014 10:08

ValiRx Narrows Half-Year Loss On Lower Costs, Progresses Pipeline

Read more
4 Aug 2014 11:12

UK MIDDAY BRIEFING: HSBC Results Below Expectations

Read more
4 Aug 2014 10:49

UK WINNERS & LOSERS: HSBC And Intertek Rise Despite Lower Profit

Read more
4 Aug 2014 07:36

ValiRx Gets Authorisation For VAL201 Trials, Shares Jump

Read more
4 Aug 2014 07:34

UK MORNING BRIEFING: UK Shares Flat Ahead Of HSBC Results

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.